Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.

The goal of this study was to identify glycosyltransferases that are specifically expressed in pancreatic cancer. To investigate the gene expression of glycosyltransferases between pancreatic cancer and normal pancreatic tissues, we performed DNA-microarray (involving about 1000 oligosaccharide-related genes) using RNA mixtures of pancreatic cancer cells and normal pancreatic tissues. Eighty-six genes were up-regulated and thirty-two were down-regulated in pancreatic cancer, compared to normal pancreatic tissue. Among these changes, it is noteworthy that the expression of GnT-IVa was decreased and the expression of GnT-IVb was increased in pancreatic cancer, compared to normal pancreatic tissues. Although GnT-IVa and -IVb are involved in the same reaction as a glycosyltransferase, their chromosomal localization is different. When 5 cases of pancreatic cancer tissues were examined using the real-time RT-PCR method, the expression of GnT-IVb was dominant in tumor tissues and the expression of GnT-IVa was dominant in the surrounding normal tissues. The expression of GnT-IVa was increased in all 3 cell lines that had been treated with 5-aza-C and butyrate. These results suggest that the down-regulation of GnT-IVa in pancreatic cancer cells is due to an epigenetic abnormality in the gene.

[1]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[2]  M. Aubert,et al.  Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells. , 2000, Cancer research.

[3]  H. Ikenaga,et al.  A novel second isoenzyme of the human UDP-N-acetylglucosamine:α1,3-D-mannoside β1,4-N-acetylglucosaminyltransferase family: cDNA cloning, expression, and chromosomal assignmen , 1998, Glycoconjugate Journal.

[4]  G. Esposito,et al.  Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma , 2005, International journal of cancer.

[5]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[6]  H. Ikenaga,et al.  Purification and Characterization of UDP-N-Acetylglucosamine: α1,3-d-Mannoside β1,4-N-Acetylglucosaminyltransferase (N-Acetylglucosaminyltransferase-IV) from Bovine Small Intestine* , 1997, The Journal of Biological Chemistry.

[7]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[8]  H. Ikenaga,et al.  cDNA Cloning and Expression of Bovine UDP-N-Acetylglucosamine:α1,3-d-Mannoside β1,4-N-Acetylglucosaminyltransferase IV* , 1998, The Journal of Biological Chemistry.

[9]  F. Gansauge,et al.  Carcinoma of the head of the pancreas arising from the uncinate process , 1998, The British journal of surgery.

[10]  Jun Wu,et al.  Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer. , 2004, World journal of gastroenterology.

[11]  Helmut Friess,et al.  Adhesion molecules in human pancreatic cancer * , 2002, Journal of surgical oncology.

[12]  T. Furukawa,et al.  Cloning and characterization of the human UDP-N-acetylglucosamine: α-1,3-D-mannoside β-1,4-N-acetylglucosaminyltransferase IV-homologue (hGnT-IV-H) gene , 1999, Journal of Human Genetics.

[13]  Y. Kanai,et al.  Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer , 1998, Japanese journal of cancer research : Gann.

[14]  H. Friess,et al.  Syndecan‐1 expression is up‐regulated in pancreatic but not in other gastrointestinal cancers , 2000, International journal of cancer.

[15]  H. Friess,et al.  Diagnosis and Staging of Pancreatic Cancer by Positron Emission Tomography , 1999, World Journal of Surgery.

[16]  Naoyuki Taniguchi,et al.  Gene expression of α1‐6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of α‐fetoprotein , 1998 .

[17]  H. Friess,et al.  Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  M. Monden,et al.  Overexpression of β1,4N-Acetylgalactosaminyl- transferase mRNA as a Molecular Marker for Various Types of Cancers , 2002, Oncology.

[19]  H. Friess,et al.  Comparative Analysis of Galectins in Primary Tumors and Tumor Metastasis in Human Pancreatic Cancer , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  J. Marth,et al.  Dietary and Genetic Control of Glucose Transporter 2 Glycosylation Promotes Insulin Secretion in Suppressing Diabetes , 2005, Cell.

[21]  P. Schlag,et al.  Altered mRNA expression of glycosyltransferases in human gastric carcinomas. , 1999, Biochimica et biophysica acta.

[22]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[23]  K. Aoki,et al.  New approaches for pancreatic cancer in Japan , 2004, Cancer Chemotherapy and Pharmacology.

[24]  R. Kannagi,et al.  Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis , 2004, Cancer science.